Optical Redox Imaging of Ex Vivo Hippocampal Tissue Reveals Age-Dependent Alterations in the 5XFAD Mouse Model of Alzheimer’s Disease
Open Access
- 25 August 2022
- journal article
- research article
- Published by MDPI AG in Metabolites
- Vol. 12 (9) , 786
Abstract
A substantial decline in nicotinamide adenine dinucleotide (NAD) has been reported in brain tissue homogenates or neurons isolated from Alzheimer’s disease (AD) models. NAD, together with flavin adenine dinucleotide (FAD), critically supports energy metabolism and maintains mitochondrial redox homeostasis. Optical redox imaging (ORI) of the intrinsic fluorescence of reduced NAD (NADH) and oxidized FAD yields cellular redox and metabolic information and provides biomarkers for a variety of pathological conditions. However, its utility in AD has not been characterized at the tissue level. We performed ex vivo ORI of freshly dissected hippocampi from a well-characterized AD mouse model with five familial Alzheimer’s disease mutations (5XFAD) and wild type (WT) control littermates at various ages. We found (1) a significant increase in the redox ratio with age in the hippocampi of both the WT control and the 5XFAD model, with a more prominent redox shift in the AD hippocampi; (2) a higher NADH in the 5XFAD versus WT hippocampi at the pre-symptomatic age of 2 months; and (3) a negative correlation between NADH and Aβ42 level, a positive correlation between Fp and Aβ42 level, and a positive correlation between redox ratio and Aβ42 level in the AD hippocampi. These findings suggest that the ORI can be further optimized to conveniently study the metabolism of freshly dissected brain tissues in animal models and identify early AD biomarkers.Keywords
Funding Information
- NIH (R01CA191207 (LZL), R01NS101156 (DMT), R21NS105437 (FEJ), R01AG077692 (FEJ, DMT))
- National Institutes of Health (UL1TR001878)
- Institute for Translational Medicine and Therapeutics of the University of Pennsylvania
This publication has 43 references indexed in Scilit:
- Relative importance of redox buffers GSH and NAD(P)H in age‐related neurodegeneration and Alzheimer disease‐like mouse neuronsAging Cell, 2014
- Quantitative metabolic imaging using endogenous fluorescence to detect stem cell differentiationScientific Reports, 2013
- Dyslipidemia and the Risk of Alzheimer’s DiseaseCurrent Atherosclerosis Reports, 2013
- A Reversible Early Oxidized Redox State That Precedes Macromolecular ROS Damage in Aging Nontransgenic and 3xTg-AD Mouse NeuronsThe Journal of Neuroscience, 2012
- Intracellular Coenzymes as Natural Biomarkers for Metabolic Activities and Mitochondrial AnomaliesBiomarkers in Medicine, 2010
- Mechanisms of mitochondrial dysfunction and energy deficiency in Alzheimer’s diseaseMitochondrion, 2007
- Intraneuronal β-Amyloid Aggregates, Neurodegeneration, and Neuron Loss in Transgenic Mice with Five Familial Alzheimer's Disease Mutations: Potential Factors in Amyloid Plaque FormationThe Journal of Neuroscience, 2006
- High-Performance Liquid Chromatography Analysis of Oxidized and Reduced Pyridine Dinucleotides in Specific Brain RegionsAnalytical Biochemistry, 1995
- Energy-Linked Pyridine Nucleotide Reduction: Inhibitory Effects of Hyperbaric Oxygen In Vitro and In VivoNature, 1965
- Metabolically Linked Changes in Fluorescence Emission Spectra of Cortex of Rat Brain, Kidney and Adrenal GlandNature, 1962